The voice of the patient

The II Alcura Summit took place a few weeks ago under the title “Overcoming hurdles to promote advancements in Cell and Gene Therapies”. Global tends and challenges were discussed by US and EU experts. All being important, at the end of the meeting there was a consensus in the importance of the voice of the patient also in this filed.

Those of us involved in developing new drugs know very well the intricate processes needed, taking years to complete and requiring the expertise of hundreds of specialists. This complexity can sometimes lead us to focus solely on the next step in the process, therefore losing sight of our true final purpose: serving patients and their doctors.

We extend our heartfelt gratitude to:

• Dr. Susana Rives, Head of the Leukemia and Lymphoma Functional Unit and Coordinator of the CAR-T Multidisciplinary Therapy Team, Hospital Sant Joan de Deu, Barcelona.
• Dr. Elena Garralda, Clinical Investigator and Executive Director of the Early Drug Development Unit, Vall d’Hebron Institute of Oncology, Barcelona.
• Mr. Andoni Lorenzo, President of Foro Espa?ol de Pacientes.
• Dr. Melqui Calzado, Public Affairs & Patient Advocacy Manager at Ferrer.

for their insights into patients’ fears, loneliness, concerns, and expectations, which have illuminated our path forward. With these considerations in mind, we are more than ever committed to enhancing our efforts and delivering better treatments.

#AlcuraSummit #Innovation #DedicatedToPatient #CellAndGene #CGT #ATMPs #AdvancedTherapies